Skip to content
BioRegenis — home

Pipeline

Six programmes in development, at very different stages of maturity. For each one we publish the real state, the next milestone and the date of the last update. Where a programme moves slowly, that shows.

How to read this page

We do not use clinical trial phase nomenclature, which would be inappropriate for devices, software and cosmetic products. We use two distinct indicators.

Technological maturity (TRL 1–9 scale)

TRL 1–2
Basic principle observed; technology concept formulated.
TRL 3–4
Experimental proof of concept; component validation in the laboratory.
TRL 5–6
Validation and demonstration in a relevant environment.
TRL 7–8
Demonstration in an operational environment; complete and qualified system.
TRL 9
System proven in a real operational environment; product on the market.

Intellectual property status

Reported as discrete states — not started, in preparation, filed (with date), under examination, granted — because a filing is an event, not a percentage of progress.

Percentages

Where present, they indicate the internal completion of the work package named alongside. They do not indicate the distance from market entry.

BRG-BCS

BioChip Skin

Digital health and biosensors

Technological maturity

28%

  1. TRL 1
  2. TRL 2
  3. TRL 3
  4. TRL 4
  5. TRL 5
  6. TRL 6
  7. TRL 7
  8. TRL 8
  9. TRL 9

TRL level TRL 3

Programme entry

BRG-PV

BioRegenis PV

Drug safety software

Technological maturity

61%

  1. TRL 1
  2. TRL 2
  3. TRL 3
  4. TRL 4
  5. TRL 5
  6. TRL 6
  7. TRL 7
  8. TRL 8
  9. TRL 9

TRL level TRL 6

Programme entry

BRG-CG

CareGamers

Personal health and performance

Technological maturity

95%

  1. TRL 1
  2. TRL 2
  3. TRL 3
  4. TRL 4
  5. TRL 5
  6. TRL 6
  7. TRL 7
  8. TRL 8
  9. TRL 9

TRL level TRL 9

Programme entry

BRG-PTLB

PT-LB

Dermocosmetic research

Technological maturity

50%

  1. TRL 1
  2. TRL 2
  3. TRL 3
  4. TRL 4
  5. TRL 5
  6. TRL 6
  7. TRL 7
  8. TRL 8
  9. TRL 9

TRL level TRL 5

Programme entry

BRG-BMG

BioRegenis Biomolecular Gen

Computational biotechnology

Technological maturity

17%

  1. TRL 1
  2. TRL 2
  3. TRL 3
  4. TRL 4
  5. TRL 5
  6. TRL 6
  7. TRL 7
  8. TRL 8
  9. TRL 9

TRL level TRL 2

Programme entry

BRG-ROB

Robotics

Devices and automation

Technological maturity

15%

  1. TRL 1
  2. TRL 2
  3. TRL 3
  4. TRL 4
  5. TRL 5
  6. TRL 6
  7. TRL 7
  8. TRL 8
  9. TRL 9

TRL level TRL 2

Programme entry

The TRL 1–9 scale measures the technological maturity of a programme: the percentage marks its position along that scale, not its distance from market entry. Programme status updated August 2026.